Anti-tumor activity of metformin in human epidermal growth factor receptor 2 positive breast cancer cells
Breast Cancer (BC) is the leading cause of cancer death in women. One BC subtype is very aggressive with amplification of human epidermal growth factor receptor 2 (HER2) protein. Although specific HER2+ targeting agents are available, most of HER2+ BC patients develop resistant to these agents....
Saved in:
Main Authors: | Huda, Fathul, Sari Ekawati,, Anindy Putri Addina,, Ahmad Faried,, Berbudi, Afiat, Rusdiana, Taofik, Tenny Putri,, Nurul Qomarilla,, Hilfi, Lukman, Setiawan, Iwan, Bashari, Muhammad Hasan |
---|---|
Format: | Article |
Language: | English |
Published: |
Penerbit Universiti Kebangsaan Malaysia
2021
|
Online Access: | http://journalarticle.ukm.my/17415/1/18.pdf http://journalarticle.ukm.my/17415/ https://www.ukm.my/jsm/malay_journals/jilid50bil5_2021/KandunganJilid50Bil5_2021.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epidermal growth factor receptor mutations in lung adenocarcinoma in Malaysian patients
by: Liam, C.K., et al.
Published: (2013) -
Epidermal Growth Factor Receptor Mutation in Newly
Diagnosed Lung Adenocarcinoma
by: Chee, Shee Chai, et al.
Published: (2017) -
In silico study of Thiourea derivatives as potential epidermal growth factor receptor inhibitors
by: Roslan, Norashikin, et al.
Published: (2023) -
Insights into the structure and drug design of
benzimidazole derivatives targeting the epidermal growth
factor receptor (EGFR)
by: Abdullah, Mar'iyah Najihah, et al.
Published: (2022) -
Qualitative Computed Tomographic Features Predict
Epidermal Growth Factor Receptor Mutations in Advanced Lung Adenocarcinoma
by: Chai, Chee Shee
Published: (2021)